Silvercrest Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.9M Sell
1,423,965
-4,505
-0.3% -$32.4K 0.08% 307
2026
Q2
$8.24M Buy
+1,428,470
New +$7.25M 0.05% 387

Other funds holding SOPH

Silvercrest Asset Management's SOPH Position: Q3 2026 in Review

Silvercrest Asset Management reduced its SOPHiA GENETICS (SOPH) stake by 0.32% in Q3 2026, selling an estimated $32.4K and leaving 1,423,965 shares worth $11.9M. The position accounts for 0.08% of the portfolio, ranked #307.

Silvercrest Asset Management first reported a position in SOPH in Q2 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • Silvercrest Asset Management held 1,423,965 shares of SOPHiA GENETICS worth $11.9M as of Q3 2026.
  • Silvercrest Asset Management sold 4,505 SOPHiA GENETICS shares in Q3 2026, an estimated $32.4K.
  • SOPHiA GENETICS made up 0.08% of Silvercrest Asset Management's portfolio in Q3 2026, its #307 holding.
  • Silvercrest Asset Management first reported a position in SOPHiA GENETICS in Q2 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Silvercrest Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.